Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Case Funding Inc.
NEW YORK, Oct. 15, 2013 /PRNewswire/ -- Case Funding Inc. recently extended its legal finance programs to include plaintiffs and attorneys involved in Medtronic Inc.'s. Sprint Fidelis Defibrillator product litigation, and today announced the expansion to include Medtronic's Infuse Bone Graft product as well. Injuries resulting from off label use of the Infuse Bone Graft have been particularly severe, and the specialty finance lender is pleased to be able to provide business financing for law firms and medical funding for plaintiffs actively involved in Infuse litigation.
"We have received many presettlement financing requests from Medtronic Infuse victims as well as from their attorneys seeking loans to pay for ongoing litigation expenses. As one of the few lenders able to provide funding for product liability cases, we are very pleased to now be able to accept Medtronic Infuse cases and fulfill a crucial need of victims and their attorneys," states Richard Silverstein, President and CEO of Case Funding.
The Medtronic Infuse Bone Graft is a device used primarily in certain spinal surgeries and is intended to foster bone growth. The product received FDA approval in 2002, but only for use with anterior lumbar fusion surgeries. In 2004, it was approved for use with tibia repairs, and in 2007 approved for use with certain dental procedures.
Over the last several years, Medtronic has faced numerous allegations suggesting that Medtronic violated the False Claims Act. It has been alleged, and so much as reported in the "Spine Journal" that Medtronic was paying various Doctors to write favorable post-market studies. Medtronic settled an action brought by the DOJ this past summer for $23.5 Million. There is some research that suggests Medtronic withheld information pertaining to the side effects and damages involved with the Infuse product.
Law firms seeking financing for Medtronic Inc. case and litigation costs or for a client should contact Leon Branam at 888 796-7594 or visit www.casefunding.com for more information on financing options and litigation involving the Medtronic Inc. Infuse bone graft.
Case Funding offers this information of its services for the review and use of experienced legal and financial professionals only. Case Funding offers no claims, promises, guarantees or advice on legal proceedings – plaintiffs and attorneys are advised to consult with an experienced professional before engaging Case Funding for services.
©2012 PR Newswire. All Rights Reserved.